# Wegovy Reduces Risk of Death from COVID-19 by 33% ### Key Points: – A recent study has shown that Wegovy, a weight loss medication, can reduce the risk of death from COVID-19 by 33%. – Wegovy, also known as semaglutide, is an injectable medication that helps people lose weight by making them feel full and less hungry. – This breakthrough finding is significant as obesity has been linked to an increased risk of severe illness and death from COVID-19. – By helping individuals achieve weight loss, Wegovy not only improves their overall health but also reduces their susceptibility to complications from COVID-19. In conclusion, the discovery that Wegovy can decrease the risk of death from COVID-19 by 33% is a major advancement in the fight against the virus, especially for individuals struggling with obesity. By promoting weight loss and improving overall health, Wegovy offers a promising solution to reduce the severity of COVID-19 outcomes. Contact Mindful Evolution today to learn more about how Wegovy can benefit your weight loss journey. Weight loss disclaimer: Individual results may vary. Mindful Evolution provides telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Contact us on our website at yourmindfulevolution.com or call or text us at 954-639-9960 for more information.